Brandinium

Trademark search for:

HAMÉ

EXPIRED USPTO USPTO

No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.

Trademark records may change over time. For the most up-to-date trademark status, domain availability, and social handle checks, run a live search.

Live search · Most up-to-date results
Also check across: EU CA AU NZ CH

USPTO Filing History

Key events recorded for this trademark application

  • 2016-03-29 — Application filed
  • 2016-08-04 — Sn assigned for sect 66a subseq desig from ib
  • 2016-08-08 — Application filed
  • 2016-08-09 — Application filed
  • 2016-08-09 — Assigned to examiner
  • 2016-08-13 — Application filed
  • 2016-08-16 — Final disposition recorded
  • 2016-08-17 — Office action issued
  • 2016-08-18 — Office action issued
  • 2016-08-18 — Office action issued
  • 2016-09-23 — Office action issued
  • 2017-03-10 — Restriction of holder's right of disposal received
  • 2017-03-16 — Application abandoned
  • 2017-03-16 — Application abandoned
  • 2017-04-27 — Limitation from the ib examined, no action is needed
  • 2018-01-10 — Notification of possible opposition sent to ib
  • 2018-01-10 — Notification of possible opposition created, to be sent to ib
  • 2018-02-09 — Notification of possible opposition - processed by ib
  • 2018-03-16 — Final disposition recorded
  • 2018-03-16 — Final disposition recorded
  • 2018-05-04 — Final disposition recorded
  • 2020-02-29 — Final status recorded
  • 2020-09-18 — Death of international registration
  • 2020-09-19 — Notification of effect of cancellation of intl reg mailed

Owner Information

Hamé s.r.o.
CZ

Correspondent

Václav Müller, patentový zástupce
Filipova 2016/6
CZ-148 00 Praha 4,
CZECH REPUBLIC

Filing Details

Filing Date:
2016-03-29
Status Date:
2020-02-29
Category:
Pharmaceuticals
Filing Year:
2016

Disclaimer: This page is informational only and does not constitute legal advice. Trademark availability depends on jurisdiction, usage, and legal interpretation.